Details of the Target
General Information of Target
| Target ID | LDTP07728 | |||||
|---|---|---|---|---|---|---|
| Target Name | Dipeptidyl peptidase 8 (DPP8) | |||||
| Gene Name | DPP8 | |||||
| Gene ID | 54878 | |||||
| Synonyms |
DPRP1; Dipeptidyl peptidase 8; DP8; EC 3.4.14.5; Dipeptidyl peptidase IV-related protein 1; DPRP-1; Dipeptidyl peptidase VIII; DPP VIII; Prolyl dipeptidase DPP8 |
|||||
| 3D Structure | ||||||
| Sequence |
MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQ
LKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPK TINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLF QAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISN IVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILR ILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVI DKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVM ERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLY KITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYF EGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLY KLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGK KYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKY KMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAP VTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAH TSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI |
|||||
| Target Type |
Clinical trial
|
|||||
| Target Bioclass |
Enzyme
|
|||||
| Family |
Peptidase S9B family, DPPIV subfamily
|
|||||
| Subcellular location |
Cytoplasm
|
|||||
| Function |
Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2. Acts as a key inhibitor of caspase-1-dependent monocyte and macrophage pyroptosis in resting cells by preventing activation of NLRP1 and CARD8. Sequesters the cleaved C-terminal part of NLRP1 and CARD8, which respectively constitute the active part of the NLRP1 and CARD8 inflammasomes, in a ternary complex, thereby preventing their oligomerization and activation. The dipeptidyl peptidase activity is required to suppress NLRP1 and CARD8; however, neither NLRP1 nor CARD8 are bona fide substrates of DPP8, suggesting the existence of substrate(s) required for NLRP1 and CARD8 inhibition.
|
|||||
| TTD ID | ||||||
| Uniprot ID | ||||||
| DrugMap ID | ||||||
| Ensemble ID | ||||||
| HGNC ID | ||||||
| ChEMBL ID | ||||||
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
DBIA Probe Info |
![]() |
C596(1.59) | LDD3331 | [1] | |
|
4-Iodoacetamidophenylacetylene Probe Info |
![]() |
N.A. | LDD0038 | [2] | |
|
IA-alkyne Probe Info |
![]() |
C221(0.00); C596(0.00) | LDD0036 | [2] | |
|
Lodoacetamide azide Probe Info |
![]() |
C221(0.00); C611(0.00); C596(0.00); C286(0.00) | LDD0037 | [2] | |
|
Acrolein Probe Info |
![]() |
N.A. | LDD0217 | [3] | |
Competitor(s) Related to This Target
| Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
|---|---|---|---|---|---|
| LDCM0215 | AC10 | HEK-293T | C211(0.98) | LDD1508 | [4] |
| LDCM0259 | AC14 | HEK-293T | C611(1.17) | LDD1512 | [4] |
| LDCM0277 | AC18 | HEK-293T | C211(1.00) | LDD1516 | [4] |
| LDCM0279 | AC2 | HEK-293T | C211(1.02) | LDD1518 | [4] |
| LDCM0282 | AC22 | HEK-293T | C611(1.56) | LDD1521 | [4] |
| LDCM0286 | AC26 | HEK-293T | C211(1.08) | LDD1525 | [4] |
| LDCM0291 | AC30 | HEK-293T | C611(0.87) | LDD1530 | [4] |
| LDCM0295 | AC34 | HEK-293T | C211(0.88) | LDD1534 | [4] |
| LDCM0299 | AC38 | HEK-293T | C611(0.90) | LDD1538 | [4] |
| LDCM0304 | AC42 | HEK-293T | C211(1.13) | LDD1543 | [4] |
| LDCM0308 | AC46 | HEK-293T | C611(1.32) | LDD1547 | [4] |
| LDCM0313 | AC50 | HEK-293T | C211(1.02) | LDD1552 | [4] |
| LDCM0317 | AC54 | HEK-293T | C611(1.04) | LDD1556 | [4] |
| LDCM0321 | AC58 | HEK-293T | C211(1.06) | LDD1560 | [4] |
| LDCM0323 | AC6 | HEK-293T | C611(0.97) | LDD1562 | [4] |
| LDCM0326 | AC62 | HEK-293T | C611(0.87) | LDD1565 | [4] |
| LDCM0108 | Chloroacetamide | HeLa | N.A. | LDD0222 | [3] |
| LDCM0368 | CL10 | HEK-293T | C611(1.09) | LDD1572 | [4] |
| LDCM0405 | CL18 | HEK-293T | C211(0.89) | LDD1609 | [4] |
| LDCM0410 | CL22 | HEK-293T | C611(1.30) | LDD1614 | [4] |
| LDCM0419 | CL30 | HEK-293T | C211(1.18) | LDD1623 | [4] |
| LDCM0423 | CL34 | HEK-293T | C611(1.35) | LDD1627 | [4] |
| LDCM0432 | CL42 | HEK-293T | C211(0.98) | LDD1636 | [4] |
| LDCM0436 | CL46 | HEK-293T | C611(0.86) | LDD1640 | [4] |
| LDCM0445 | CL54 | HEK-293T | C211(1.28) | LDD1648 | [4] |
| LDCM0449 | CL58 | HEK-293T | C611(1.21) | LDD1652 | [4] |
| LDCM0451 | CL6 | HEK-293T | C211(0.85) | LDD1654 | [4] |
| LDCM0458 | CL66 | HEK-293T | C211(0.89) | LDD1661 | [4] |
| LDCM0463 | CL70 | HEK-293T | C611(1.03) | LDD1666 | [4] |
| LDCM0471 | CL78 | HEK-293T | C211(1.14) | LDD1674 | [4] |
| LDCM0476 | CL82 | HEK-293T | C611(1.30) | LDD1679 | [4] |
| LDCM0485 | CL90 | HEK-293T | C211(1.16) | LDD1688 | [4] |
| LDCM0489 | CL94 | HEK-293T | C611(1.06) | LDD1692 | [4] |
| LDCM0022 | KB02 | HEK-293T | C611(1.14) | LDD1492 | [4] |
| LDCM0023 | KB03 | HEK-293T | C611(1.09) | LDD1497 | [4] |
| LDCM0024 | KB05 | MKN-1 | C596(1.59) | LDD3331 | [1] |
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Phase 3
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Talabostat | Small molecular drug | D0FQ2U | |||
Investigative
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| 1g244 | Small molecular drug | D0CP1J | |||
| Pmid15664838c18 | Small molecular drug | D02RDY | |||
| Pmid20684603c24dd | Small molecular drug | D08NMS | |||
Patented
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Thiomorpholine Derivative 1 | Small molecular drug | D06HJX | |||
| Thiomorpholine Derivative 2 | Small molecular drug | D0D4BP | |||
References





